Comparing the effect of clomiphene and estradiol valerate with letrozole
Phase 3
- Conditions
- Female infertility.Female infertility
- Registration Number
- IRCT2015052612789N11
- Lead Sponsor
- Vice Chancellor for Research, Kurdistan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
polycystic ovary syndrome based on Rotterdam Criteria; age between 18 to 48 years old; menstrual disturbances (oligomenorrhea or amenorrhea); clinical or biochemical hyperandrogenism.
Exclusion criteria: hyperprolactinemia; thyroid problems; anatomical probleb of uterin cavity and fallopian tubes which is approved by hsterosalpingography.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Endometrial thickness. Timepoint: Day 14 of the menstrual cycle. Method of measurement: Transvaginal ultrasound.;Pregnancy. Timepoint: One month after the menstrual cycle. Method of measurement: positive BHCG and ultrasound.;Abortion. Timepoint: Three months (in the case of Pregnancy). Method of measurement: The patient's medical record.
- Secondary Outcome Measures
Name Time Method Endometrial thickness improvement. Timepoint: On day 14 of the menstrual cycle. Method of measurement: Transvaginal ultrasound.